Mobile Phones and Multidrug Resistant Bacteria: A Growing Concern for Healthcare Workers
Abstract
Healthcare workers' mobile phones can potentially transmit a range of pathogenic bacteria causing Hospital acquired infections to patients and community. The study was conducted to determine the prevalence of bacterial contamination of mobile phones of healthcare workers, assessing the kinds of bacterial isolates, their antibiotic susceptibility and resistance patterns, and the factors contributing to contamination. A cross-sectional study was conducted at Elhwari Nephro Center including 125 health care workers. Demographic data, and data regarding antibiotic usage history as well as mobile cleaning behaviour were collected using a structured questionnaire. Antimicrobial susceptibility testing was performed for all the collected mobile swabs samples. Data analysis using SPSS version 28. Prevalence rates of resistant micro-organisms were revealed together with the corresponding patterns of antibiotic susceptibility. Results are presented using tables for clarity. The overall prevalence of mobile phone contamination was 84% of swabbed samples. The most common bacterial isolate was pseudomonas aeruginosa 21.6% followed by E. coli 20.8%, staphylococcus epidermidis 16.8%, Klebsiella pneumonia 14.4%, staphylococcus aureus 6.4%, and clostridium spp 4%. Most isolates were susceptible to levofloxacin (98.1%), ciprofloxacin (88.6%), and ceftriaxone (84.8%). Vancomycin showed limited effectiveness specifically against staphylococcus aureus with only 13% susceptibility. 86.7% and 71.2%…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.